Pathophysiology of Allergic and Nonallergic Rhinitis
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Allergic and nonallergic rhinitis affect approximately 30% of the U.S. population. Although allergic rhinitis has a clear definition and its pathophysiology has been thoroughly investigated, nonallergic rhinitis remains poorly defined and understood. There is consensus, however, that nonallergic rhinitis consists of a variety of heterogeneous conditions. In allergic rhinitis, the process of allergen sensitization involves the participation of antigen-presenting cells, T lymphocytes, and B lymphocytes and depends on environmental allergen exposure. Sensitization results in the generation of allergen-specific IgE that circulates in the peripheral blood and attaches itself on the surface of all mast cells and basophils including those that home to the nasal mucosa. Subsequent nasal exposure to allergen activates these cells and, through the release of the classic mediators of the allergic reaction, produces acute nasal symptoms. Over a short period of time, these symptoms become indolent, whereas inflammatory and immune cell infiltrate, including eosinophils, basophils, neutrophils, T lymphocytes, and monocytes, characterizes the late stages of the allergic response. In parallel, and probably as a result of the development of mucosal inflammation, the nose becomes primed to allergen and reacts more vigorously to subsequent allergen exposure but also becomes hyperresponsive to irritants and to changes in atmospheric conditions. In nonallergic rhinitis, several conditions may have been identified that are of interest for further research and phenotyping. These include a group of patients with apparent hyperresponsiveness of the C-fiber sensory nerves with no inflammatory changes in the nasal mucosa and a group with mucosal eosinophilia who may have allergic sensitization to common aeroallergens that is, however, manifested only in the nasal mucosa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IgE is produced by B-cells under the influence of Th2 effector cells and the cytokines they secrete.275”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [275]
In the citing paper
“They also provide an important early stimulus toward a Th2-weighted immune response, through the secretion of thymic stromal lymphopoietin (TSLP).272,275,276”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [275]
In the citing paper
“The process begins with exposure of the nasal mucosa to inhalant allergens.275”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [275]
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
Liu, Y.-J. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115633 · Cited by 1,625
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032058 · Cited by 1,052
Schleimer, R. P., Sterbinsky, S. A., Kaiser, J., Bickel, C. A., Klunk, D. A., Tomioka, K., Newman, W., Luscinskas, F. W., Gimbrone, M. A., & McIntyre, B. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1086 · Cited by 818
Flood-Page, P. T., Menzies-Gow, A. N., Kay, A. B., & Robinson, D. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-789oc · Cited by 808
Inflammatory Mediators in Late Antigen-Induced Rhinitis
Naclerio, R. M., Proud, D., Togias, A. G., Adkinson, N. F., Meyers, D. A., Kagey-Sobotka, A., Plaut, M., Norman, P. S., & Lichtenstein, L. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507113130201 · Cited by 692
Self-citationMediator Release after Nasal Airway Challenge with Allergen
Naclerio, R. M., Creticos, P. S., Norman, P. S., & Lichtenstein, L. M. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1102 · Cited by 562
The Nose, upper airway physiology and the atmospheric environment
Proctor, D. F., & Andersen, I. (1982) · Elsevier eBooks · Cited by 513
Weller, P. F., Lee, C. W., Foster, D. W., Corey, E. J., Austen, K. F., & Lewis, R. A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.24.7626 · Cited by 476
Research works printed but not linked: 10
- 1980, Rhinology, 18, 183
- 1972, J Neurocytol, I, 49
- 2007, Clin Allergy Immunol, 19, 267
- 2005, Clin Exp Allergy, 36, 26
- 1996, Clin Exp Allergy, 26, 677, 10.1111/j.1365-2222.1996.tb00594.x · doi:10.1111/j.1365-2222.1996.tb00594.x · Paper page
- 1983, Am Rev Respir Dis, 128, 597
- 1990, Immunology, 71, 258
- 1999, J Appl Physiol, 86, 1202
- 2002, Rhinology, 40, 1
- 1997, Clin Exp Allergy, 27, 796
Cited by
Wheatley, L. M., & Togias, A. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1412282 · Cited by 606
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Karimy, J. K., Zhang, J., Kurland, D. B., Theriault, B. C., Duran, D., Stokum, J. A., Furey, C. G., Zhou, X., Mansuri, M. S., Montejo, J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4361 · Cited by 410
Steelant, B., Farré, R., Wawrzyniak, P., Belmans, J., Dekimpe, E., Vanheel, H., Van Gerven, L., Kortekaas Krohn, I., Bullens, D. M. A., Ceuppens, J. L., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.050 · Cited by 336
Allergic Rhinitis: A Clinical and Pathophysiological Overview
Nur Husna, S. M., Tan, H.-T. T., Md Shukri, N., Mohd Ashari, N. S., & Wong, K. K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.874114 · Cited by 265
“FIGURE 2 | Schematic presentation of pathophysiology of AR (12, 59, 64, 66).”
BackgroundReview of Rhinitis: Classification, Types, Pathophysiology
Liva, G., Karatzanis, A. D., & Prokopakis, E. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143183 · Cited by 158
“Then, antigen-presenting cells (APCs) break antigens into antigenic peptides and migrate to lymph nodes to present the peptides to naïve CD4+ T lymphocytes (T cells) [13].”
BackgroundBjermer, L. H., Westman, M., Holmström, M., & Wickman, M. C. (2019) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0314-1 · Cited by 132
Watts, A. M., Cripps, A. W., West, N. P., & Cox, A. J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00294 · Cited by 121
“This second signal stimulates B cell activation and class switch recombination to induce IgE production (Sin and Togias, 2011).”
BackgroundInfluentialGenetics and Epigenetics in Allergic Rhinitis
Choi, B. Y., Han, M. S., Kwak, J. W., & Kim, T. H. (2021) · Genes · doi:10.3390/genes12122004 · Cited by 113
“Upon re-exposure, the allergen attaches to IgE on the surface of mast cells and circulating basophils, resulting in activation of those cells and the release of histamine and leukotrienes [5,6].”
BackgroundRhinitis Subtypes, Endotypes, and Definitions
Papadopoulos, N. G., & Guibas, G. V. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.12.001 · Cited by 111
“formed bioactive mediators (eg, histamine, leukotrienes, prostaglandins, plateletactivating factor).(35,37) A late-phase reaction typically follows up to 4 to 12 hours later, as a result of the release of chemokines and other chemoattractants that cause Th2 cells, activated eosinophils, and mast cells to migrate into…”
BackgroundIL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma
Husna, S. M. N., Shukri, N. M., Ashari, N. S. M., & Wong, K. K. (2022) · PeerJ · doi:10.7717/peerj.13444 · Cited by 109
Intranasal formulations: promising strategy to deliver vaccines
Riese, P., Sakthivel, P., Trittel, S., & Guzmán, C. A. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.931936 · Cited by 110
“The nasal anatomy and the composition of the nasal mucosa have been formerly reviewed in great detail [9-11].”
BackgroundPollen calendars and maps of allergenic pollen in North America
Lo, F., Bitz, C. M., Battisti, D. S., & Hess, J. J. (2019) · Aerobiologia · doi:10.1007/s10453-019-09601-2 · Cited by 91
Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis
König, K., Klemens, C., Eder, K., Nicoló, M. S., Becker, S., Kramer, M. F., & Gröger, M. (2015) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-015-0093-x · Cited by 87
“Activated eosinophils release granules containing amongst others eosinophil cationic protein (ECP) and major basic protein (MBP) [10].”
BackgroundPiao, C. H., Song, C. H., Lee, E. J., & Chai, O. H. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108874 · Cited by 84
Oxidative Stress and Antioxidant Pathway in Allergic Rhinitis
Han, M. S., Lee, D., Lee, S. H., & Kim, T. H. (2021) · Antioxidants · doi:10.3390/antiox10081266 · Cited by 88
Krug, N., Gupta, A., Badorrek, P., Koenen, R., Mueller, M., Pivovarova, A., Hilbert, J., Wetzel, K., Hohlfeld, J. M., & Wood, C. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.013 · Cited by 57
“Inflammation in patients with AR is heterogeneous because it is derived from a variety of cell types, and therapies targeting a single mediator are often not sufficient to resolve all the different symptoms or underlying inflammation.(1,2) There is a need for agents with pharmacologically broad anti-inflammatory mecha…”
BackgroundHyun, D., Min, H. J., Kim, M., Whon, T. W., Shin, N.-R., Kim, P. S., Kim, H. S., Lee, J., Kang, W., Choi, A. M. K., et al. (2018) · Infection and Immunity · doi:10.1128/iai.00934-17 · Cited by 62
“Allergic rhinitis (AR) is a nasal allergic disease characterized by nasal hyperresponsiveness, immunoglobulin E (IgE) production, skewing of mucosal immune homeostasis toward a TH2-type response, and accumulation of eosinophils and mast cells (1, 2).”
BackgroundBui, T. T., Piao, C. H., Song, C. H., & Chai, O. H. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.029 · Cited by 57
Rahim, N. A., Jantan, I., Said, M. M., Jalil, J., Razak, A. F. A., & Husain, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.660083 · Cited by 59
Immunomodulatory effects of IL ‐23 and IL ‐17 in a mouse model of allergic rhinitis
Wang, M., Zhang, W., Shang, J., Yang, J., Zhang, L., & Bachert, C. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12123 · Cited by 52
Olfactory dysfunction in seasonal and perennial allergic rhinitis
Becker, S., Pflugbeil, C., Gröger, M., Canis, M., Ledderose, G., & Kramer, M. F. (2012) · Acta Oto-Laryngologica · doi:10.3109/00016489.2012.656764 · Cited by 54
“When allergen-specific IgE is attached to the surface of the cell and subsequent allergen exposure on the nasal mucosa takes place, bridging of adjoining IgE antibodies by the allergen leads to a liberation of different mediators such as tryptase, leukotrienes or histamine [16].”
BackgroundOvercoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
Bridgeman, M. B. (2017) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s129544 · Cited by 59
“The symptoms produced by this immediate hypersensitivity reaction typically last for ~1 hour and then dissipate.(14,15) Approximately 50% of patients with allergic rhinitis then experience a late-phase response that may persist for hours after allergen exposure.”
BackgroundNew Insights into the Role of PD-1 and Its Ligands in Allergic Disease
Galván Morales, M. A., Montero-Vargas, J. M., Vizuet-de-Rueda, J. C., & Teran, L. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111898 · Cited by 45
Gelardi, M., Iannuzzi, L., & Quaranta, N. A. A. (2013) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21193 · Cited by 51
“Exudate 2 (1, 2) 1 (0, 2) 1 (1, 2) 1 (1, 2) 3.”
MethodAllergic rhinitis: Disease characteristics and coping measures in Saudi Arabia
Almehizia, A. A., AlEssa, R. K., Alwusaidi, K. M., Alzamil, K. A., AlJumah, M., Aljohani, S. S., Almutairi, A. F., & Salam, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217182 · Cited by 47
Bergougnan, C., Dittlein, D., Hümmer, E., Riepl, R., Eisenbart, S., Böck, D., Griesbaum, L., Weigl, A., Damialis, A., Hartwig, A., et al. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100109 · Cited by 46
“AR is characterized by acute, recurrent, or chronic Th2- and IgE-mediated inflammation of the nasal mucosa, involving the activation of resident mast cells and dendritic cells as well as tissue infiltration by immune cells.(4) The nasal epithelium of AR patients is characterized by mucus hypersecretion, edema, goblet…”
BackgroundDiagnosis and Management of Allergic Rhinitis in Asthmatic Children
Tenero, L., Vaia, R., Ferrante, G., Maule, M., Venditto, L., PIACENTINI, G. L., Senna, G., & Caminati, M. (2023) · Journal of Asthma and Allergy · doi:10.2147/jaa.s281439 · Cited by 53
“of IgE molecules activates an intracellular signalling cascades leading to the degranulation of bioactive mediators (eg, histamine, leukotrienes, prostaglandins, platelet activating factor).(2,6) Delayed or persistent nasal inflammation is sus-”
BackgroundJones, P., Koolhof, I. S., Wheeler, A. J., Williamson, G. J., Lucani, C. J., Campbell, S. L., Bowman, D. M. J. S., Cooling, N., Gasparrini, A., & Johnston, F. H. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111484 · Cited by 45
“However, it is well known that there is often a physiologically biphasic clinical response to aeroallergens and this can produce lagged concentration-response relationships (Sin and Togias, 2011).”
BackgroundZonula occludens and nasal epithelial barrier integrity in allergic rhinitis
Sarah, C. O. S., Shukri, N. M., Ashari, N. S. M., & Wong, K. K. (2020) · PeerJ · doi:10.7717/peerj.9834 · Cited by 43
Tsai, T., Lei, W., Kuo, C., Sun, H., Su, P., & Wang, S. (2020) · Environment International · doi:10.1016/j.envint.2020.106243 · Cited by 41
Kinetic oscillation stimulation as treatment of non-allergic rhinitis: an RCT study
Juto, J., & Axelsson, M. (2014) · Acta Oto-Laryngologica · doi:10.3109/00016489.2013.861927 · Cited by 33
A novel and effective approach to treating rhinitis with nasal antihistamines
Kaliner, M. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60560-1 · Cited by 31
Backaert, W., Steelant, B., Hellings, P. W., Talavera, K., & Gerven, L. V. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00981-x · Cited by 35
Zhu, X., Sun, Y., Yu, Q., Wang, X., Wang, Y., & Zhao, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110450 · Cited by 30
Common Allergens and Immune Responses Associated with Allergic Rhinitis in China
Li, Q., Zhang, X., Feng, Q., Zhou, H., Ma, C., Lin, C., Wang, D., & Yin, J. (2023) · Journal of Asthma and Allergy · doi:10.2147/jaa.s420328 · Cited by 33
“IL-4, IL-5, and IL-13 interact with B cell surface receptors, inducing ε germline transcription to produce immunoglobulins.(63) The second signal is produced by the costimulatory interaction between CD154 (CD40 ligand) on the surface of activated T cells and CD40 molecules on the surface of B cells; this interaction a…”
BackgroundInfluentialLi, H., Kreiner, J., Wong, A. R., Li, M., Sun, Y., Lu, L., Liu, J., & Yang, A. W. H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7037 · Cited by 29
“Allergic rhinitis (AR) is a common allergen-induced immunoglobulin E (IgE)-mediated inflammatory disease that affects the nasal mucosa membranes (Sin & Togias, 2011).”
BackgroundNishimura, T., Kaminuma, O., Saeki, M., Kitamura, N., Matsuoka, K., Yonekawa, H., Mori, A., & Hiroi, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146686 · Cited by 29
“AR is also characterized by submucosal inflammation associated with massive accumulation of inflammatory cells including eosinophils and T cells, like other allergic diseases [1,3].”
BackgroundShahzad, K. A., Wang, Z., Li, X., Li, J., Xu, M., & Tan, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429442 · Cited by 31
“AR is characterized by Th1, Th2 and IgE mediated disorder which involve the activation of mast cells, eosinophils and dendritic cells by hyperresponsiveness of allergens such as pollens, fungal spores, or house-dust mite (42).”
BackgroundPharmacological Benefits of Triphala: A Perspective for Allergic Rhinitis
Jantrapirom, S., Hirunsatitpron, P., Potikanond, S., Nimlamool, W., & Hanprasertpong, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.628198 · Cited by 31
“The pathophysiology of AR is quite complex (Figure 2), beginning with sensitization and early and late-phase responses (Min, 2010; Sin and Togias, 2011).”
BackgroundHua, T., Li, S., & Han, B. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2339335 · Cited by 29
“However, under pathological conditions such as rhinitis, not only does the permeability of the nasal epithelium change, but also the congested thickening of the mucosal layer and increased secretions disrupt the nasal cavity’s homeostasis, posing challenges for nanomedicines therapy [17,19,20].”
BackgroundAllakhverdi, Z., Comeau, M. R., Armant, M. A., Agrawal, R., Woodfolk, J. A., Sehmi, R., Howie, K. J., Gauvreau, G. M., & Delespesse, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00461 · Cited by 27
“The observation that the MCs mediators could induce TSLP production by BM-MSCs only in the presence of TNF could explain how chronic inflammation increases the sensitization of the airways to the allergen (33, 34).”
BackgroundPathophysiology of and potential new therapies for allergic rhinitis
Osguthorpe, J. D. (2013) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21120 · Cited by 26
Kim, E. H., Lee, J.-S., Lee, N. R., Baek, S. Y., Kim, E. J., Lee, S., & Kim, I. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105814 · Cited by 26
“Rhinitis is classified as allergic or non-allergic based on allergen sensitization [1,2].”
BackgroundRole of microRNAs in inflammatory upper airway diseases
Tubita, V., Callejas, F. D. B., Roca‐Ferrer, J., Marín, C., Liu, Z., Wang, D. Y., & Mullol, J. (2020) · Allergy · doi:10.1111/all.14706 · Cited by 29
Comparing the Effects of Botulinum Toxin-A and Cetirizine on the Treatment of Allergic Rhinitis
Hashemi, S. M., Okhovat, A., Amini, S., & Pourghasemian, M. (2013) · Allergology International · doi:10.2332/allergolint.12-oa-0510 · Cited by 27
Beard, S. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2013.10.005 · Cited by 32
“The cells break the allergens into antigenic peptides.(5) APCs present the antigenic peptides to naive T cells (Th0).”
InfluentialReliability of Basophil Activation Test Using CD203c Expression in Diagnosis of Pollen Allergy
Özdemir, S. K., Güloğlu, D., Sin, B. A., Elhan, A. H., İkincioğulları, A., & Mısırlıgil, Z. (2011) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2011.25.3723 · Cited by 23
Self-citationLee, N. R., Baek, S. Y., Gu, A., Kim, D. H., Kim, S. Y., Lee, J.-S., & Kim, I. S. (2015) · Immunologic Research · doi:10.1007/s12026-015-8730-5 · Cited by 23
“There are many differences between normal and allergic subjects such as varying total and HDM-specific IgE, eosinophil, and inflammatory cytokine levels [1, 30, 31].”
BackgroundLin, Y.-P., Kao, Y. C., Pan, W., Yang, Y., Chen, Y., & Lee, Y. L. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000447367 · Cited by 23
Shimizu, S., Takezawa, K., Ogawa, T., Tojima, I., Kouzaki, H., & Shimizu, T. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.11.010 · Cited by 21
“Mucus hypersecretion and eosinophil infiltration are common characteristics of allergic airway inflammation[3].”
BackgroundJoudi, M., Hosseini, R. F., Khoshkhui, M., Salehi, M., Kouzegaran, S., Ahoon, M., & Azad, F. J. (2019) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2019.11.6.885 · Cited by 19
Qiu, S., Du, Y., Duan, X., Geng, X., Xie, J., Gao, H. J., & Yang, P. (2011) · North American Journal of Medical Sciences · doi:10.4297/najms.2011.3378 · Cited by 19
“etc [7].”
A novel microRNA miR-1165-3p as a potential diagnostic biomarker for allergic asthma
Wu, C., Xu, K., Wang, Z., Chen, Z., Sun, Z., Yu, W., Ji, N., Huang, M., & Zhang, M. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1501762 · Cited by 19
Vieira, G. C., Gadelha, F. A. A. F., Pereira, R. F., Ferreira, L. K. D. P., Barbosa‐Filho, J. M., Bozza, P. T., & Piuvezam, M. R. (2017) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2017.10.009 · Cited by 18
Caillaud, D. M., Chanez, P., Escamilla, R., Burgel, P., Court‐Fortune, I., Nesme‐Meyer, P., Deslée, G., Perez, T., Pinet, C., & Roche, N. (2013) · Respirology · doi:10.1111/resp.12224 · Cited by 19
Restimulia, L., Ilyas, S., Munir, D., Putra, A. B., Madiadipoera, T. H. S., Farhat, F., Sembiring, R., Ichwan, M., Amalina, N. D., & Alif, I. (2021) · Medical Archives · doi:10.5455/medarh.2021.75.256-261 · Cited by 17
“DISCUSSION Allergic rhinitis is a common inflammatory disease worldwide characterized by a well‐defined phenotype, such as frequent sneezing, breathing difficulty, and increased airway resistance (29-31).”
BackgroundXu, H., He, J., Du, H., Jing, X., & Liu, X. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70085 · Cited by 16
“However, CSF hyperse-cretion from the CPE may resemble the hypersecretory phenotypes in other inflamed epithelia [41, 42].”
BackgroundLee, T. K., Jeon, Y. J., & Jung, S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-83787-9 · Cited by 17
Hu, Z., Xue, J., Pan, M., Bao, Y., Zou, W., Wang, C., & Ma, J. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04291-9 · Cited by 16
“The etiology of AR is still unclear and its pathogenesis is likely related to the combined influences of both genetic and environmental factors [3, 14].”
BackgroundSO2 activates Th17 cells through the JAK1,2/STAT3 signaling pathway
Ye, M., Deng, G., Liu, Q., Jiang, X., Wang, T., Tan, G., Ai, J., & Liu, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113263 · Cited by 16
Correlation of microRNA profiles with disease risk and severity of allergic rhinitis.
Jia, M., Chu, C., & Wang, M. (2018) · PubMed · Cited by 17
Gelincik, A. A., Aydın, F., Edis, B. Ö., Ergüven, M., Aydın, S., Bılır, A., Genç, S., Eroğlu, H., Çolakoğlu, B., Erden, S., et al. (2012) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2012.04.006 · Cited by 15
“[1] Sin B, Togias A.”
Wang, H., Ji, Q., Liao, C., & Tian, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1287320 · Cited by 16
“Leukotrienes mainly participate in the late-phase reaction of allergic rhinitis, leading to persistent nasal congestion (Sin and Togias, 2011).”
BackgroundThe Relationship of Climate Change to Rhinitis
Kim, J., & Rouadi, P. W. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.04.012 · Cited by 13
Pyun, B., Lee, J. Y., Kim, Y. J., Ji, K.-Y., Jung, D. H., Park, K.-S., Jo, K., Choi, S., Jung, M., Kim, Y. H., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14100986 · Cited by 13
Immunotherapy in the Treatment of Allergic Rhinitis in Children
Alamri, R. A., Aljabri, G. H., Tahlawi, R., & Aljabri, H. A. (2022) · Cureus · doi:10.7759/cureus.32464 · Cited by 16
“Cellular recruitment of basophils, neutrophils, T-lymphocytes, monocytes, and eosinophils, as well as the release of numerous mediators, such as cytokines, prostaglandins, and leukotrienes, which support the inflammatory response, are characteristic of this phase [11-12].”
BackgroundJin, J., Fan, Y. J., Nguyen, T. V., Yu, Z. N., Song, C. H., Lee, S., Shin, H. S., & Chai, O. H. (2024) · Foods · doi:10.3390/foods13040611 · Cited by 13
“Numerous inflammatory cells (such as eosinophils and mast cells), cytokines, and additional regulatory molecules are also involved in the AR inflammatory process [6].”
BackgroundPrins, S. D., Marcucci, F., Sensi, L. G., de Mieroop, E. V., Nelen, V., Nawrot, T. S., Schoeters, G. E. R., & Koppen, G. (2014) · Biomarkers · doi:10.3109/1354750x.2014.937362 · Cited by 12
“Rhinitis can be both allergic and non-allergic in nature (Sin & Togias, 2011).”
BackgroundKhanzadeh, M., Nematollahi, S. F., Shavakhi, M., Ghaedi, A., Mallahi, A., Bazrgar, A., & Khanzadeh, S. (2023) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-023-04148-8 · Cited by 12
“Treg cells can suppress inflammation by secreting interleukins and can cause apoptosis in inflammatory T-cells like Th2 by expressing CD279 (aka programmed death 1) and CD152 (aka cytotoxic T-lymphocyte antigen) [45, 46].”
Smallwood, D., Ledford, D. K., Kennedy, D., & Lockey, R. F. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.04.030 · Cited by 10
Cheong, P. K., Ho, T. M., Chan, K. L., Lo, C. W., Leung, S. B., Hon, K. E., Leung, K. C., Siu, T. H. C., Song, T.-H., Zhang, H., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1058176 · Cited by 11
“And so, it has been suggested that there is an imbalance of Th2 and Treg-cell in AR patients (Sin and Togias, 2011).”
BackgroundNasal Physiology and Sinusitis
Davraj, K., Yadav, M., Chappity, P., Sharma, P., Grover, M., Sharma, S., Kataria, T., Bhawna, K., Pendakur, A., Singh, G., et al. (2021) · Springer eBooks · doi:10.1007/978-981-33-6284-0_3 · Cited by 15
Piao, C. H., Kim, M., Bui, T. T., Hyeon, E., Fan, Y. J., Song, C. H., Jeong, H., & Chai, O. H. (2019) · Mediators of Inflammation · doi:10.1155/2019/1936769 · Cited by 10
“In addition, an allergic response is triggered after allergen-specific IgE and Th2 cells recognize exposed allergens in the environment, and its inflammatory process is involved with many different inflammatory cells including eosinophils and mast cells, cytokines, and other regulatory molecules [33, 34].”
BackgroundEnhanced airway sensory nerve reactivity in non-eosinophilic asthma
Ali, H., Brooks, C., Crane, J., Beasley, R. W., Holgate, S. T., Gibson, P. G., Pattemore, P., Tzeng, Y., Stanley, T., Pearce, N. E., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000974 · Cited by 9
Zonula occludens-1 expression is reduced in nasal epithelial cells of allergic rhinitis patients
Sarah, C. O. S., Husna, S. M. N., Shukri, N. M., Wong, K. K., & Ashari, N. S. M. (2022) · PeerJ · doi:10.7717/peerj.13314 · Cited by 12
Natural Course of Allergic and Nonallergic Rhinitis After 2 Years in Korean Children
Lee, S., Choi, J. H., Suh, J. D., Chung, S., Hong, S., Kim, J. K., & Cho, J. H. (2016) · Clinical and Experimental Otorhinolaryngology · doi:10.21053/ceo.2015.01130 · Cited by 9
“For the exact differential diagnosis, allergy tests including the skin prick test or the measurement of specific IgE is essential [3-5].”
BackgroundMohamed, A., El-Nabarawi, M. A., Teaima, M. H. M., Abdel-Haleem, K. M., Ragab, G. M., Abo-Zalam, H. B., & Elhabal, S. F. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107452 · Cited by 8
Thamrongsak, C., Chirdkiatgumchai, V., Jotikasthira, W., Kiewngam, P., Kanchongkittiphon, W., & Manuyakorn, W. (2022) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2022.111138 · Cited by 8
Ishino, T., Oda, T., Kawasumi, T., Takemoto, K., Nishida, M., Horibe, Y., Chikuie, N., Taruya, T., Hamamoto, T., Ueda, T., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042113 · Cited by 8
“This leads to the cross-linking of IgE antibodies on inflammatory cells, initiating mast cell degranulation and the release of various mediators such as PAF, histamine, and pro-inflammatory cytokines [6,7].”
BackgroundSuppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophilic inflammation
Koyama, T., Miura, K., Yamasaki, N., Ogata, S., Ito, D., Saeki, M., Hiroi, T., Mori, A., & Kaminuma, O. (2021) · Asia Pacific Allergy · doi:10.5415/apallergy.2021.11.e25 · Cited by 8
“Inflammatory responses in the nasal mucosa are characteristic features of allergic rhinitis (AR) [1].”
BackgroundMeng, C., Sha, J., Li, L., An, L., Zhu, X., Xun, M., Zhu, D., & Dong, Z. (2014) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2014.28.4065 · Cited by 7
Kumar, B., & Deshmukh, R. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128295952240306072100 · Cited by 7
Vitamin D Deficiency Is Correlated with Severity of Allergic Rhinitis
Sudiro, M., Lestari, B. W., Madiadipoera, T. H. S., Setiabudiawan, B., & Boesoirie, T. S. (2017) · OALib · doi:10.4236/oalib.1103813 · Cited by 7
“It is known that cytokines and mediators are involved in the development of allergic rhinitis, Th2 are dominant cell type and produce Interleukin (IL)-4, IL-5, IL-9, IL-13 and granulocyte-macrophage colony stimulating factor (GM-CSF) which contribute to the inflammatory response [4] [5].”
BackgroundSchapochnik, A., Klein, S., Brochetti, R. A., Alonso, P. T., Damazo, A. S., Destro, M. F. D. S. S., Hamblin, M. R., & Lino‐dos‐Santos‐Franco, A. (2021) · Lasers in Medical Science · doi:10.1007/s10103-021-03456-1 · Cited by 7
Teo, C. W. L., Png, S. J. Y., Ung, Y. W., & Yap, W. N. (2022) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-022-00695-x · Cited by 7
“The cross-linking of IgE antibody on the surface of the activated inflammatory cells triggers mast cell degranulation in the early phase of allergic response, releasing preformed and newly synthesized mediators such as platelet-activating factor (PAF), histamine and proinflammatory cytokines that promote vascular perm…”
BackgroundLevels of IgE sensitization drive symptom thresholds in allergic rhinitis
Dimou, M. V., Xepapadaki, P. V., Lakoumentas, J., Mageiros, L., Aggelidis, X., Antonopoulou, M., Bakakos, P., Botskariova, S., Chliveros, K., Chrysoulakis, S., et al. (2024) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2024.04.026 · Cited by 7
Rajapakse, S., Amarasiri, L., Yasaratne, D., Warnasekara, J. N., & Agampodi, S. B. (2022) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmac017 · Cited by 6
Richards, G. A., McDonald, M., Gray, C. L., de Waal, P., Friedman, R., Hockman, M., Karabus, S. J., Lodder, C. M., Mabelane, T., Mosito, S. M., et al. (2023) · South African Family Practice · doi:10.4102/safp.v65i1.5806 · Cited by 11
Effect of VBC-1814/7J, a poly-phytocompound, on a non-infectious model of pharyngitis
Uemura, J., Nagpal, R., Zerbinati, N., Singh, B., Marcellino, M. G., Mohania, D., Marotta, F., He, F., Ayala, A., Kasugai, Y., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4332 · Cited by 6
“These are groups of polypeptides that play a pivotal role in orchestrating the inflammatory response, further increasing the cellular infiltration and cellular activation (26,27), but also inducing defensins in respiratory tract epithelial cells (28).”
BackgroundSingh, A. K., Shaili, S., Siddiqui, A., Ali, A., Choubey, A., Jain, P., Mirza, M. A., & Iqbal, Z. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1636415 · Cited by 6
“The development of nasal hyperresponsiveness and more latent symptoms, along with the inflammatory cells’ recruitment and activation, are characteristics of the late phase (17).”
Nasal nitric oxide measurement in allergic rhinitis and non-allergic rhinitis: a meta-analysis
Dahlan, A. F., Islam, M. A., Shukri, N. M., & Abdullah, B. (2024) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-n2634 · Cited by 6
“In vasomotor rhinitis, there is evidence of neurogenic dysregulation, contributing to nasal hyper-reactivity and increased nasal congestion 39 .”
BackgroundSong, J. Y., Ha, E. K., Sheen, Y. H., Kim, M., Lee, S. W., Yoon, J. W., Lee, S. J., Jung, Y., Lee, K. S., Ahn, J., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12902 · Cited by 7
Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment
Ueda, S., Miura, K., Kawasaki, H., Ogata, S., Yamasaki, N., Miura, S., Mori, A., & Kaminuma, O. (2022) · Biomolecules · doi:10.3390/biom12050674 · Cited by 5
YAMAYA, Y., & WATARI, T. (2014) · Journal of Veterinary Medical Science · doi:10.1292/jvms.14-0338 · Cited by 5
“In addition, the number of CCR4-positive lymphocytes also increases in airway epithelial cells of human patients with allergic CR and asthma, but not in those with non-allergic rhinitis and other lung diseases, such as chronic obstructive pulmonary disease [1, 20, 21].”
BackgroundAllergic Rhinitis and Conjunctivitis
Corren, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37579-5.00008-8 · Cited by 6
Zihlif, M. A., Abusara, O. H., Al-Qerem, W. A., Al-Ibadah, M. A., Mahafza, T. M., Al-Akhras, F. M., & Mahafza, N. T. (2023) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2023-0014 · Cited by 6
Lopes, A. P., Azenha, P., Teodósio, C., Inácio, M., da Silva, I. C. B., Loureiro, G., Martinho, A., Luís, A. S., Trindade, H., Pereira, C., et al. (2013) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-9-40 · Cited by 4
“Rhinitis can be caused by nonallergic factors like infection, hormones or others [1,2], although approximately 50% of all cases are allergy-related.”
BackgroundThe Toxicant Induction of Irritant Asthma, Rhinitis, and Related Conditions
Meggs, W. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9044-9 · Cited by 7
Metadata
- Authors
- Sin, B., & Togias, A.
- Affiliations
- Ankara University, School of Medicine, Ankara, Turkey; and
- National Institute of Allergy and Infectious Diseases (US)
- ORCID
- Togias, Alkis
- Venue
- Proceedings of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-01
- Volume
- 8
- Issue
- 1
- Pages
- 106-114
- ISSN
- 1546-3222 (ISSN-L)
- 1943-5665
- OpenAlex
- W2086750691
- Cited by
- 176
- References
- 90
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 14 · 2023: 14 · 2022: 26 · 2021: 22 · 2020: 10 · 2019: 11 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 10 · 2012: 5
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Proceedings of the American Thoracic Society (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- allergic rhinitis, non-allergic rhinitis, pathophysiology, allergen sensitization, IgE, mast cells, basophils, eosinophils, nasal mucosa inflammation, aeroallergens, T cells, B cells
- MeSH terms
- Acute Disease, Age Factors, Allergens, Chronic Disease, Female, Rhinitis, Allergic, Seasonal, Humans, Male, Nasal Mucosa, Rhinitis, Rhinitis, Allergic, Perennial, Severity of Illness Index, Disease Progression, Risk Assessment, Airway Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.